Evaluating a Digital Tool for Supporting Breast Cancer Patients (ADAPT)

Royal Marsden NHS Foundation Trust

Status: Unknown

Conditions: Breast Cancer

Treatments: Device: OWise

Study type: Interventional

Funder types: Other

Identifiers

NCT03866655

CCR4965

Details and patient eligibility

About

This is a prospective randomised controlled trial that aims to understand the impact of the OWise breast cancer digital tool in newly diagnosed breast cancer patients. Half the patients will receive the digital tool and half the patients will receive standard information. The study will look at the impact of the digital tool on patient activation, health related quality of life (HRQoL), health status, psychological distress, NHS resource utilisation and health care costs.

Enrollment: 165 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• female
• adult (age 18 years or over)
• newly diagnosed
• early breast cancer
• first primary cancer diagnosis
• under treatment at one of the participating sites.

Exclusion criteria

• have started anti-cancer treatment
• private patients
• unable to read or write in English
• significant cognitive impairment
• poor mental health
• do not have access to the internet
• confirmed metastatic disease

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

165 participants in 2 patient groups

Intervention

Experimental group

Treatment:

Device: OWise

Control

No Intervention group